Home › Cataract › NCT06987474
Capella Scientia Development Study
RecruitingObservational study
Capella Scientia (SCDX) Development Study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Able to understand and sign an IRB/IEC approved consent form; * Willing and able to attend study visit(s) as required by the protocol; * Consenting age at the jurisdiction of study site; * Other group-specific, protocol required inclusion criteria may apply. Exclusion Criteria: * Women of child-bearing potential; * Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus); * Unclear optical media preventing data capture from all devices in the study; * Contraindicated for pupil dilation (e.g., narrow angles, allergies) per investigator's clinical judgment; * Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study results, or may interfere significantly with the subject's participation in the study; * Other group-specific, protocol required exclusion criteria may apply.
About the study
This study involves collecting biometry and aberration data using the next generation biometer, Unity DX.
What is being tested
- Unity DX and SMARTCataract DX (SCDX) Biometer (device)
- IOLMaster 700 Biometer (device)
- Argos with Alcon Image Guidance Biometer (device)
Sponsor: Alcon Research · Participants: 400 · Started: Jul 30, 2025
Contact the study team
- Alcon Call Center · Phone: 1-888-451-3937
Official record on ClinicalTrials.gov — NCT06987474
Locations in the U.S.
| Utah | The Eye Institute of Utah, Salt Lake City |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.